Biophan to Present at ValueRich Small-Cap Financial Expo.ROCHESTER, N.Y. -- Biophan Technologies, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BIPH BIPH Bogomoletz Institute of Physiology (National Academy of Sciences; Ukraine) ; FWB (Fixed Wireless Broadband) See fixed wireless. : BTN BTN In currencies, this is the abbreviation for the Bhutan Ngultrum. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ), a developer of next-generation medical technology, today announced Michael Weiner Michael Weiner can refer to:
On Thursday, October 26, 2006, at 1:00 p.m. ET, the live presentation can be accessed at the following link: https://valuerichonline.webex.com/valuerichonline/onstage/g.php?p=0&t= m (Due to its length, this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists). When the screen opens, select "Room 1" at the bottom of the screen; then click on "Enroll." An article about Biophan appeared in the Summer 2006 issue of ValueRich. The article may be viewed at http://www.valuerichonline.com/mag/06summer/cocostory.php?id=biph. For additional information about Biophan Technologies, please contact Jim Blackman at 713-256-0369 or jimblackman@prfinancialmarketing.com. About ValueRich ValueRich, Inc. operates various online and offline media-based properties for corporate and financial professionals. ValueRich operates a web community, publishes ValueRich magazine, http://www.valuerichonline.com/mag, and hosts large scale ValueRich Small-cap Financial Expos annually. The Company's corporate mission is to create the world's largest community of Wall Street professionals and small-cap public company executives through an integrated portfolio of products and services associated with their global Web community, print publishing and large-scale financial events. About Biophan Biophan is dedicated to providing technologies that offer innovative and competitive advantages to the medical device industry. The Company licenses its technologies which improve the MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. safety and image compatibility of medical devices to leading device manufacturers. In addition, the Company is helping to commercialize the MYOTECH MYO-VAD[TM], a new, MRI-compatible cardiac recovery system which has significant potential to improve the treatment of many forms of heart disease. Biophan is traded on the OTC market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange over-the-counter market under the symbol BIPH, and is also listed on the Frankfurt Stock Exchange Frankfurt Stock Exchange The largest of Germany's eight securities exchanges, operated by Deutsche Borse AS. under the symbol BTN. For more information on Biophan, please visit our website at www.biophan.com. Cautionary Statement Regarding Forward-Looking Statements Certain statements included in this press release may constitute forward-looking statements within the meaning of applicable securities laws. These statements reflect what Biophan anticipates, expects, or believes may happen in the future. Biophan's actual results could differ materially from the outcome or circumstance expressed or implied by such forward-looking statements as a result of a variety of factors including, but not limited to: Biophan's ability to develop its technologies; the approval of Biophan's patent applications; the successful implementation of Biophan's research and development programs; the ability of Biophan to demonstrate the effectiveness of its technology; the acceptance by the market of Biophan's technology and products incorporating such technology; the ability of Biophan to effectively negotiate and enter into contracts with medical device manufacturers for the licensing of Biophan's technology; competition; the ability of Biophan to raise capital to fund its operating and research and development activities until it generates revenues sufficient to do so; and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in Biophan's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Biophan's periodic filings with the SEC, which are incorporated herein by reference. The forward-looking statements contained herein are made only as of the date of this press release, and Biophan undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion